The long-standing focus of our laboratory program involves the radiation and microenvironmental stress response. We are now focusing on """"""""radiation inducible molecular targets"""""""" that is, exploring the use of fractionated radiation to induce a cellular phenotype that makes the cell susceptible for molecular targeted therapy. In essence, radiation would set up the tumor for enhanced drug killing. This project has now demonstrated that different dose sizes of radiation (10 Gy x1, 2 Gy x5 and 1 Gy x10) produce different phenotypes. We have demonstrated that the cells post-radiation are more drug sensitive for at least 1 drug and much more work is in progress but we are now working on combinations of drugs. This work fits into molecular targeted cancer treatment using both the """"""""non-oncogene addiction targets"""""""" and """"""""synthetic lethality"""""""" We have made significant progress in studying the inducible mRNA, miRNA and proteins. We have expanded to add a p53 proficient cell line. Five manuscripts are in now published (Radiation Research Journal) including an overview of the field in Molecular Cancer Therapeutics. Projects now in progress include studying metabolomic changes, in vivo SD and MF for PC3 cells, and exploring epigenetic changes. We are also identifying pathways to target and working on timing of radiation and drug(s). Indirectly related to this work are efforts being done in the Office of the Assistant Secretary for Preparedness and Response in Health and Human Services (HHS). I am heading a group developing civilian medical response planning for radiological and nuclear terrorism and other events. This involves planning, policy, and normal tissue injury-related science. Medical countermeasures are being developed through NIAID support in the Centers for Medical Countermeasures Against Radiation (CMCR). This overall program has major impact to U.S. preparedness and also has a spin-off for normal tissue injury from radiation and the potential for post-exposure mitigators and treatments. We are working with other agencies (NIAID and Dept of Defense) on the potential of bringing these mitigators into cancer care. The critical importance of the NCI- HHS linkage is bringing up-to-date scientficia thinking to medical countermeasure development and diagnosis

National Institute of Health (NIH)
National Cancer Institute (NCI)
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Cancer Institute Division of Basic Sciences
Zip Code
Eke, Iris; Makinde, Adeola Y; Aryankalayil, Molykutty J et al. (2018) Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example. Mol Cancer Ther 17:355-367
Aryankalayil, Molykutty J; Chopra, Sunita; Makinde, Adeola et al. (2018) Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model. Biomarkers :1-15
Ahmed, Mansoor M; Coleman, C Norman; Mendonca, Marc et al. (2018) Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint. Cancer Res 78:2166-2170
Eke, Iris; Makinde, Adeola Y; Aryankalayil, Molykutty J et al. (2018) Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer. Mol Cancer Res 16:1855-1864
Aryankalayil, Molykutty J; Chopra, Sunita; Levin, Joel et al. (2018) Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation. Radiat Res 189:251-263
Vanpouille-Box, Claire; Alard, Amandine; Aryankalayil, Molykutty J et al. (2017) DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nat Commun 8:15618
Coleman, C Norman (2017) The Radiation Stress Response: Of the People, By the People and For the People. Radiat Res 187:129-146
FitzGerald, Thomas J; Bishop-Jodoin, Maryann; Followill, David S et al. (2016) Imaging and Data Acquisition in Clinical Trials for Radiation Therapy. Int J Radiat Oncol Biol Phys 94:404-11
Makinde, Adeola Y; Eke, Iris; Aryankalayil, Molykutty J et al. (2016) Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted Therapy. Semin Radiat Oncol 26:254-60
Coleman, C Norman; Higgins, Geoff S; Brown, J Martin et al. (2016) Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials. Clin Cancer Res 22:3138-47

Showing the most recent 10 out of 29 publications